Head-to-head · WeighScore
Evolve Telemed vs Get Thin MD
The verdict
Get Thin MD takes it — 66.7/100 to 58.1/100.
Get Thin MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Get Thin MD is a nationwide async telehealth platform offering compounded semaglutide and tirzepatide injections plus brand-name Ozempic and Zepbound where appropriate, alongside a broader wellness menu…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Evolve Telemed | Get Thin MD |
|---|---|---|
| WeighScore | 58.1/100 | 66.7/100 |
| Grade | C | C |
| Scorecard rank | #378 | #184 |
| Semaglutide | Not disclosed | $199/mo (compounded) |
| Tirzepatide | Not disclosed | $299/mo (compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #378 · C
Strengths
- Established hormone- and peptide-optimization brand with board-certified specialists and a physician-plus-care-specialist support model
- Compounded GLP-1 (semaglutide) weight care offered alongside TRT, menopause/BHRT, thyroid and sexual-wellness programs in one practice
- Coordinated couples care plans plus dedicated men's and women's tracks
- Free consultation to start, with published press, blog and FAQ resources
Where it loses points
- No GLP-1 pricing published — cost is only revealed after a consultation, so you can't compare value upfront
- Doesn't list the states it serves or name its compounding pharmacies
- Weight loss is one of many verticals, not a dedicated GLP-1-first program
- Tirzepatide availability isn't confirmed on the site; only compounded semaglutide is referenced
- Not shown on our price-ranked /best lists because no pricing is disclosed
Graded #184 · C
Strengths
- 3-month compounded semaglutide at $169/mo is among the lowest ongoing prices in the category
- Price-lock promise — same price every dose, no hidden fees
- Both compounded and brand-name options on one platform (sema, tirz, plus Ozempic and Zepbound)
- Nationwide availability with async evaluation — no in-person visit
- Broader wellness menu (sermorelin, NAD+, HRT, hair loss) lets you consolidate protocols
Where it loses points
- Compounded medications aren't FDA-approved and lack the review of brand-name GLP-1s
- Pharmacy partners not named — no way to verify the compounding source or batch testing
- Claims nationwide coverage but publishes no state list — confirm at intake
- Headline results (9.6 lbs in 30 days) come from self-reported patient data, not a trial
- Wide wellness funnel may steer you toward non-weight-loss protocols
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.